Terms: = Prostate cancer AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919 AND Treatment
4 results:
1. Wnt/β-catenin signaling contributes to prostate cancer heterogeneity through reciprocal suppression of H3K27 trimethylation.
Wang F; Zhu Y; Wang F; Wang Y; Dong BJ; Wang N; Gao WQ
Biochem Biophys Res Commun; 2020 Jun; 527(1):242-249. PubMed ID: 32446375
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA-34a Attenuates Paclitaxel Resistance in prostate cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract] [Full Text] [Related]
3. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
4. prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity.
de Bessa Garcia SA; Pavanelli AC; Cruz E Melo N; Nagai MA
Int J Mol Med; 2017 Apr; 39(4):809-818. PubMed ID: 28259909
[TBL] [Abstract] [Full Text] [Related]
